Head-to-head · WeighScore
RestorLife Med vs Wisp
The verdict
Wisp takes it — 75/100 to 63.2/100.
Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | RestorLife Med | Wisp |
|---|---|---|
| WeighScore | 63.2/100 | 75/100 |
| Grade | C | C |
| Scorecard rank | #262 | #59 |
| Semaglutide | $299/mo (microdose tier, compounded) | $225/mo (compounded oral) |
| Tirzepatide | $399/mo (microdose tier, compounded) | $99/mo (starting dose, brand-name) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #262 · C
Strengths
- Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
- Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
- Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
- Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
- Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12
Where it loses points
- Compounded medications are not FDA-approved as finished products (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Ongoing pricing is mid-range ($299/mo semaglutide, $399/mo tirzepatide) after the discounted first month
- The specific partner compounding pharmacy is not named
- Also markets hormone therapy and anti-aging peptides, not GLP-1 exclusively
Graded #59 · C
Strengths
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
Where it loses points
- Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
- Pharmacy partners not named
- States served not listed publicly
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.